CN Patent
CN104098497B — 一种新的酰胺类化合物
Assigned to Individual · Expires 2016-04-13 · 10y expired
What this patent protects
一种新化合物(式I所示)及其盐,实验证明可以用于治疗和预防脑缺血性疾病、改善睡眠,可以与碱金属钠、镁、钾、钙和有机碱tris、二乙胺、三乙胺等生成盐,具有治疗和预防缺血性心脑血管疾病和改善睡眠的作用。
USPTO Abstract
一种新化合物(式I所示)及其盐,实验证明可以用于治疗和预防脑缺血性疾病、改善睡眠,可以与碱金属钠、镁、钾、钙和有机碱tris、二乙胺、三乙胺等生成盐,具有治疗和预防缺血性心脑血管疾病和改善睡眠的作用。
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.